Premium
Sutimlimab, an investigational C1s inhibitor, effectively prevents exacerbation of hemolytic anemia in a patient with cold agglutinin disease undergoing major surgery
Author(s) -
Tvedt Tor Henrik A.,
Steien Egil,
Øvrebø Bente,
Haaverstad Rune,
Hobbs William,
Wardęcki Marek,
Tjønnfjord Geir Erland,
Berentsen Sigbjørn Andreas
Publication year - 2022
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26409
Subject(s) - medicine , cold agglutinin , hemolysis , hemolytic anemia , haptoglobin , autoimmune hemolytic anemia , immunology , cold agglutinin disease , extracorporeal circulation , hemopexin , complement system , anemia , gastroenterology , chemistry , antibody , heme , biochemistry , enzyme
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom